AU5641096A - A pharmaceutical composition useful in treating alcohol depe ndence or abuse comprising at least one partial agonist of 5 -th1a receptors and at least one selective inhibitor of mono amino-oxidase - Google Patents
A pharmaceutical composition useful in treating alcohol depe ndence or abuse comprising at least one partial agonist of 5 -th1a receptors and at least one selective inhibitor of mono amino-oxidaseInfo
- Publication number
- AU5641096A AU5641096A AU56410/96A AU5641096A AU5641096A AU 5641096 A AU5641096 A AU 5641096A AU 56410/96 A AU56410/96 A AU 56410/96A AU 5641096 A AU5641096 A AU 5641096A AU 5641096 A AU5641096 A AU 5641096A
- Authority
- AU
- Australia
- Prior art keywords
- ndence
- th1a
- depe
- abuse
- oxidase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR9501972A BR9501972A (en) | 1995-05-09 | 1995-05-09 | Pharmaceutical composition method for treating alcohol dependence or abuse and method for treating psychiatric disorders genetically related to alcoholism |
BR9501972 | 1995-05-09 | ||
PCT/BR1996/000018 WO1996035425A1 (en) | 1995-05-09 | 1996-05-09 | A pharmaceutical composition useful in treating alcohol dependence or abuse comprising at least one partial agonist of 5-th1a receptors and at least one selective inhibitor of monoamino-oxidase |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5641096A true AU5641096A (en) | 1996-11-29 |
Family
ID=4061341
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU56410/96A Abandoned AU5641096A (en) | 1995-05-09 | 1996-05-09 | A pharmaceutical composition useful in treating alcohol depe ndence or abuse comprising at least one partial agonist of 5 -th1a receptors and at least one selective inhibitor of mono amino-oxidase |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0824351A1 (en) |
AU (1) | AU5641096A (en) |
BR (1) | BR9501972A (en) |
WO (1) | WO1996035425A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2768338B1 (en) * | 1997-09-17 | 1999-10-15 | Synthelabo | PHARMACEUTICAL COMPOSITIONS CONTAINING A MONOAMINE OXIDASE INHIBITOR AND THEIR THERAPEUTIC APPLICATION |
AU2002354017B2 (en) | 2001-11-05 | 2007-08-16 | Krele Pharmaceuticals, Inc. | Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism |
RU2327448C1 (en) | 2007-05-23 | 2008-06-27 | Виктор Иванович Рощин | Medicinal agent for ethyl alcohol and/or narcotic addiction treatment, parmaceutical composition, active ingredient of pharmaceutical composition, method of ethyl alcohol and/or narcotic addiction treatment for alcoholics' and/or narcotists' psychosomatic and neurological complication treatment |
RU2366430C2 (en) | 2007-05-23 | 2009-09-10 | Виктор Иванович Рощин | Monoaminooxidase inhibitors, therapeutic agent and pharmaceutical composition |
CA2809966C (en) | 2010-09-01 | 2019-01-08 | Tonix Pharmaceuticals, Inc. | Treatment for ***e addiction |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4999382A (en) * | 1988-10-26 | 1991-03-12 | Massachusetts Institute Of Technology | Compositions for treating tobacco withdrawal symptoms and methods for their use |
-
1995
- 1995-05-09 BR BR9501972A patent/BR9501972A/en not_active Application Discontinuation
-
1996
- 1996-05-09 WO PCT/BR1996/000018 patent/WO1996035425A1/en not_active Application Discontinuation
- 1996-05-09 EP EP96913395A patent/EP0824351A1/en not_active Withdrawn
- 1996-05-09 AU AU56410/96A patent/AU5641096A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP0824351A1 (en) | 1998-02-25 |
WO1996035425A1 (en) | 1996-11-14 |
BR9501972A (en) | 1997-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ305254A (en) | Farnesyl protein inhibitors and pharmaceutical compositions thereof | |
EP0863748A4 (en) | Liposomal compositions and methods of using them | |
IL122813A0 (en) | Thrombin inhibitors their preparation and use | |
AU5439996A (en) | Compositions and methods for treating pain | |
AU5911798A (en) | Apparatus and method for treating chronic constipation | |
AUPN698495A0 (en) | Improved therapeutic formulation and method | |
AU1273297A (en) | Flame inhibitor composition and use thereof | |
AU4266596A (en) | Composition and use | |
GB2298713B (en) | Method and composition | |
AU1117497A (en) | Analgesic compounds and uses thereof | |
AU4981896A (en) | Liposome composition and method for administering liposome-loadable drugs | |
EG21286A (en) | Blends of organosillane compounds and their use | |
PL324461A1 (en) | Synergic herbicidal composition and method of using same | |
AU7090196A (en) | Inhibitors of integrin receptors and their therapeutical uses | |
AU4761996A (en) | Conformationally constrained reverse-turn library and methods relating thereto | |
AU4623196A (en) | Process and composition for cleaning surfaces | |
AU5641096A (en) | A pharmaceutical composition useful in treating alcohol depe ndence or abuse comprising at least one partial agonist of 5 -th1a receptors and at least one selective inhibitor of mono amino-oxidase | |
AU683601B2 (en) | Use of an antioxidizing and/or antiradical agent in a screening composition for cosmetic or dermatological use | |
AUPN137895A0 (en) | Composition and method | |
AU5578096A (en) | Compositions and methods for inducing dermal analgesia | |
AU2224195A (en) | Medicinal composition for treating tardive dyskinesia and utilization thereof | |
AU5774796A (en) | Pharmaceutical compositions containing lornoxicam and cyclod extrin | |
GB9517658D0 (en) | Treatment of cellulosic material and compositions for use in this | |
GB2302506B (en) | A composition for use in eradicating pests and a method of manufacturing such a composition | |
AU2558197A (en) | Sheet dispenser and method of using same |